-
公开(公告)号:EP3207029B1
公开(公告)日:2021-08-04
申请号:EP15850240.1
申请日:2015-10-15
IPC分类号: A61K31/405 , A61K36/74 , A61P25/00 , A61P43/00 , C07D209/16
-
公开(公告)号:EP3273995B1
公开(公告)日:2021-07-14
申请号:EP16711320.8
申请日:2016-03-23
发明人: DESSEN, Arne , MYRSET, Astrid Hilde , RYE, Philip
IPC分类号: A61K31/443 , A61K31/405 , A61K31/4164 , A61K31/4245 , A61K31/43 , A61K31/47 , A61K31/496 , A61K31/4965 , A61K31/7036 , A61K31/734 , A61K45/06 , A61P11/00
-
公开(公告)号:EP3814338A1
公开(公告)日:2021-05-05
申请号:EP19744945.7
申请日:2019-06-27
IPC分类号: C07D405/14 , C07D491/08 , C07D403/06 , C07D403/14 , C07D417/14 , C07D451/02 , C07D451/06 , A61P25/00 , A61P25/16 , A61P25/28 , A61K31/4025 , A61K31/405
-
34.
公开(公告)号:EP3810120A2
公开(公告)日:2021-04-28
申请号:EP19728593.5
申请日:2019-05-24
发明人: CUENOUD, Bernard , SEVERIN, India,C
IPC分类号: A61K31/19 , A61K31/405 , A61K31/4425 , A61K31/455 , A61K31/706 , A61P25/28
-
公开(公告)号:EP3809882A1
公开(公告)日:2021-04-28
申请号:EP19837761.6
申请日:2019-07-19
申请人: MEND Nutrition Inc.
发明人: SYED, Eziah , DRYER, Hans , OWEN, Erin C.
IPC分类号: A23L33/175 , A61K31/198 , A61K31/405 , A61K31/4172
-
36.
公开(公告)号:EP3795148A1
公开(公告)日:2021-03-24
申请号:EP20205401.1
申请日:2014-03-04
申请人: ALLERGAN, INC.
IPC分类号: A61K31/197 , A61K31/198 , A61K31/405 , A61K31/4406 , A61K9/00 , A61P27/00 , A61P27/02 , A61P29/00 , A61P29/02
摘要: The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2.
-
公开(公告)号:EP3235877B1
公开(公告)日:2021-03-17
申请号:EP15869990.0
申请日:2015-12-15
发明人: ENOMURA Masakazu , ARAKI Kaeko , HONDA Daisuke
IPC分类号: C09B67/20 , B01J19/00 , C08J3/12 , C09B67/12 , B01J19/18 , A61K9/14 , A61K31/12 , A61K31/405 , A61K31/5383 , C09B67/00
-
公开(公告)号:EP3763363A1
公开(公告)日:2021-01-13
申请号:EP19764416.4
申请日:2019-03-05
申请人: AJINOMOTO CO., INC.
IPC分类号: A61K31/198 , A23L33/175 , A61K31/405 , A61K31/4172 , A61P25/22 , A61P25/28
摘要: The present invention provides a composition for improving cognitive function, a composition for improving anxiety-like symptoms, and a composition for suppressing cerebral atrophy containing one or more kinds selected from the group consisting of 25 mol% - 45 mol% of leucine, and 20 mol% - 40 mol% of phenylalanine relative to the total content of leucine, lysine, valine, isoleucine, phenylalanine, histidine and tryptophan, which are highly safe and can be ingested or administered continuously.
-
公开(公告)号:EP2968315B1
公开(公告)日:2020-06-03
申请号:EP14763038.8
申请日:2014-03-17
发明人: BAR-OR, David , THOMAS, Greg
IPC分类号: A61K31/496 , A61K38/12 , A01N25/00 , A61K31/20 , A61K31/405 , A61K31/495 , A61K35/28 , A61K35/32 , C12N5/0775 , A61P19/02
-
公开(公告)号:EP3074006B1
公开(公告)日:2020-04-01
申请号:EP14808684.6
申请日:2014-11-28
IPC分类号: A61K31/381 , A61K31/404 , A61K31/405 , A61K31/41 , A61P31/04 , A61P43/00
-
-
-
-
-
-
-
-
-